Case Reports
Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.
Court of Appeal Maintain Status Quo in Neurim v Mylan By Refusing Injunctive Relief
In the latest flurry of judgments to arise from the Neurim v Mylan (now trading as Viatris) battle over Neurim's insomnia patent and Mylan's presence on the market with its generic version, we report...
Neurim v Mylan – Is it finally all wrapped up or is the door still open for round 3?
Following on from Mr Justice Meade's judgment on the preliminary issues in the re-match between Neurim (and Flynn) and Generics (UK) Ltd (now trading as Viatris but formerly Mylan) concerning a...
Déjà vu in melatonin rematch as Neurim v Mylan (Take II) marches on in the UK
With a back catalogue to rival Bob Dylan, the latest development in the Neurim – Mylan battle over Mylan's generic melatonin product saw Mr Justice Meade referee the trial of preliminary issues in...
Developer’s Forensic Examination of Agreement Still Unsuccessful in Appeal Against Former Employer
The Court of Appeal has upheld the first instance judgment in Penhallurick v MD5 Limited and agreed that MD5 Limited ("MD5") still owns the copyright of the works in this dispute; and thus dismissing...
Duchess of Sussex held to be entitled to reasonable expectation of privacy and copyright in letter to father
On 11 February 2021, the High Court ruled in favour of the Duchess of Sussex, Meghan Markle, in her dispute against Associated Newspapers over the publication of a number of articles in ‘The Mail on...
Please try updating your search criteria.
The UPC Newsletter
Get expert insights and the top patent stories delivered straight to your inbox.